Subgroup analysis of possible correlations between clinical outcome and hrgA/hpyIIIR status suggested that the prevalence of the hrgA gene was increased among gastric cancer patients (42%) in East Asian countries compared with that in patients without gastric cancer (17%) [14]. The gene discussed is NRG1; the disease is gastric cancer.